| Product Information |
BR-1225_PI_01.pdf
|
| Registration Number |
BR-1225
|
| Generic Name |
Insulin Degludec + Liraglutide
|
| Brand Name |
Xultophy
|
| Dosage Strength |
100 U/3.6 mg/mL
|
| Dosage Form |
Solution for Injection (SC)
|
| Classification |
Prescription Drug (RX)
|
| Packaging |
3 mL Type I glass cartridge with bromobutyl and isoprene laminate rubber and red bromobutyl rubber plunger assembled in a pen injector (Box of 5's)
|
| Pharmacologic Category |
-
|
| Manufacturer |
Novo Nordisk A/S
|
| Country of Origin |
Denmark
|
| Trader |
N/A
|
| Importer |
Novo Nordisk Pharmaceuticals (Philippines), Inc.
|
| Distributor |
Novo Nordisk Pharmaceuticals (Philippines), Inc.
|
| Application Type |
Initial (from Monitored Release)
|
| Issuance Date |
24 October 2022
|
| Expiry Date |
10 August 2027
|